Newsroom

LEEDS, England--(BUSINESS WIRE)--Varco Energy (Varco), ein wegweisender, in Großbritannien ansässiger Eigentümer und Betreiber von Batteriespeichersystemen, der vom Adaptogen Capital Battery Storage Fund unterstützt wird, freut sich bekannt zu geben, dass das Unternehmen Lieferverträge für sein 100-MW-/244-MWh-Batterie-Energiespeichersystem (BESS) Old Allen Road in West Yorkshire unterzeichnet hat. Highlights: Das BESS Old Allen Road erweitert Varcos Portfolio aus in Betrieb befindlichen und im...

LEEDS, Angleterre--(BUSINESS WIRE)--Varco Energy (Varco), société britannique pionnière dans la détention et l’exploitation d’actifs de stockage par batterie, soutenue par l’Adaptogen Capital Battery Storage Fund, a le plaisir d’annoncer la signature de contrats de fourniture pour son système de stockage d’énergie par batterie (BESS) de 100 MW/244 MWh situé à Old Allen Road, dans le West Yorkshire. Points clés : Le BESS d’Old Allen Road ajoute 100 MW au portefeuille de projets opérationnels et...

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers and acquirers of Regencell Bioscience Holdings Limited (NASDAQ: RGC) securities between October 28, 2024 and October 31, 2025, inclusive (the “Class Period”). Regencell is a purported early-stage bioscience company.For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653.The Allegations: Rosen Law Firm is Investigating th...

LONDON--(BUSINESS WIRE)--  Re: Corporación Andina de Fomento USD 59,000,000.00 MATURING: 31-Mar-2028 ISIN: XS2606327109 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 31-Mar-2026 TO 30-Jun-2026 HAS BEEN FIXED AT 4.78 PCT DAY BASIS: ACTUAL/360 INTEREST PAYABLE VALUE 30-Jun-2026 WILL AMOUNT TO: USD 12,093.24 PER USD 1,000,000.00 DENOMINATION  ...

NEW YORK--(BUSINESS WIRE)--The International Insurance Society (IIS) announced the RGA Leaders of Tomorrow class of 2026....

SEATTLE--(BUSINESS WIRE)--Syndio, the Decision Intelligence for Pay company, today announced the acquisition of Embrace.ai, an agentic AI company built to deploy AI-driven automation across business workflows. The full Embrace.ai team, led by founders and enterprise software veterans Derek Butts and Seth Halpern, will join Syndio’s product and go-to-market organization. The acquisition bolsters the Syndio team with deep experience across enterprise human capital management (HCM), large-scale so...

LONDON--(BUSINESS WIRE)--  Re: Nordic Investment Bank NOK 1,000,000,000.00 MATURING: 24-Mar-2027 ISIN: XS2461770070 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 24-Jun-2026 TO 24-Sep-2026 HAS BEEN FIXED AT 5.57 PCT DAY BASIS: ACTUAL/360 INTEREST PAYABLE VALUE 24-Sep-2026 WILL AMOUNT TO: NOK 42,703,333.33 PER NOK 3,000,000,000.00 DENOMINATION  ...

SAN DIEGO--(BUSINESS WIRE)--FairJourney Bio (“FJBio”), a global antibody discovery expert, has entered a partnership with AbTherx, Inc. to bring transgenic mouse-based antibody discovery in-house. The agreement gives the Company access to AbTherx’s Atlas™ Full Human Diversity (FHD) and Common Light Chain (cLC) mouse technologies, completing a discovery route that partners can now run end to end entirely within FJBio’s integrated workflow. From the partnership, a programme can now move from immu...

LONDON--(BUSINESS WIRE)--  Re: Inter-American Development Bank USD 300,000,000.00 MATURING: 28-Mar-2033 ISIN: US4581X0EZ72 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 27-Mar-2026 TO 29-Jun-2026 HAS BEEN FIXED AT 4.05 PCT DAY BASIS: ACTUAL/360 INTEREST PAYABLE VALUE 29-Jun-2026 WILL AMOUNT TO: USD 10.57 PER USD 1,000.00 DENOMINATION  ...

NEW YORK--(BUSINESS WIRE)--Pathway Labs today announced its public launch of EchoNext, the world’s first FDA-approved AI detection tool that reads standard 12-lead electrocardiograms (ECGs) to flag high risk structural heart diseases for patients. Receiving FDA clearance for six indications, Pathway Labs also announced its partnership with OpenEvidence to make EchoNext available on the AI platform regularly used by over half of US clinicians. EchoNext detects heart conditions that clinicians ca...